Business Context and Reporting Period
This Form 6-K filing by Sanofi-Aventis covers the month of February 2007. The report serves to incorporate by reference a press release dated February 9, 2007, regarding a specific legal development.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a legal disclosure rather than a financial results report.
Material Changes
The material change disclosed is the outcome of a patent infringement lawsuit concerning the product LOVENOX®. The suit was decided against Sanofi-Aventis.
Outlook, Risks, and Contingencies
Legal Contingency: The company faces a negative legal ruling in a patent infringement suit regarding LOVENOX®. The filing does not provide specific details on the financial impact, settlement amounts, or future operational risks associated with this decision.
Investor Verification Checklist
- Verify the specific financial penalties or damages awarded against Sanofi-Aventis in the LOVENOX® patent suit.
- Confirm the impact of the ruling on the commercial availability or pricing of LOVENOX®.
- Review the full text of the press release (Exhibit 99.1) for details on potential appeals or ongoing litigation.
- Check subsequent filings for any updates on the financial provision related to this legal loss.